The field of diabetes treatment is undergoing a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide stand out as potential game-changers. These of https://jaysonkatp291506.qowap.com/97960387/novel-glp-1-receptor-agonists-retatrutide-and-trizepatide